Neurofilament light is a treatment‐responsive biomarker in CLN2 disease-Reference-Cited by-同舟云学术

Neurofilament light is a treatment‐responsive biomarker in CLN2 disease

Published:2019-12 Issue:12 Volume:6 Page:2437-2447
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Ru Yuanbin¹^ORCID,Corado Carley²,Soon Russell K.³,Melton Andrew C.³,Harris Adam³^ORCID,Yu Guoying K.¹,Pryer Nancy³,Sinclair John R.²,Katz Martin L.⁴,Ajayi Temitayo⁵,Jacoby David⁵^ORCID,Russell Chris B.³^ORCID,Chandriani Sanjay¹^ORCID

Affiliation:

1. Research BioMarin Pharmaceutical Inc. Novato California 94949

2. Pharmacological Sciences BioMarin Pharmaceutical Inc. Novato California 94949

3. Translational Sciences BioMarin Pharmaceutical Inc. Novato California 94949

4. Department of Ophthalmology School of Medicine University of Missouri Columbia Missouri 65212

5. Clinical Sciences BioMarin Pharmaceutical Inc. Novato California 94949

Funder

BioMarin Pharmaceutical

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.50942

Reference52 articles.

1. CLN2

2. The neuronal ceroid-lipofuscinoses

3. Management Strategies for CLN2 Disease

4. The neuronal ceroid-lipofuscinoses: A historical introduction

5. Study of Intraventricular Cerliponase Alfa for CLN2 Disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of neurofilament light chain to identify structural brain diseases in dogs;Journal of Veterinary Internal Medicine;2024-05-22

2. Neurofilaments as biomarkers in neurological disorders — towards clinical application;Nature Reviews Neurology;2024-04-12

3. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges;Clinical Chemistry and Laboratory Medicine (CCLM);2024-01-15

4. Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study;The Lancet Neurology;2024-01

5. Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease;Neurology;2023-08-08